Statements (17)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
gptkb:Gerhard_Koenig
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:focusesOn |
neurodegenerative diseases
lysosomal biology |
| gptkbp:foundedIn |
2018
|
| gptkbp:founder |
gptkb:Duane_Burnett
gptkb:Gerhard_Koenig |
| gptkbp:fundedBy |
gptkb:Series_B
|
| gptkbp:headquartersLocation |
gptkb:Cambridge,_Massachusetts
|
| https://www.w3.org/2000/01/rdf-schema#label |
Arkuda Therapeutics
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:therapeuticArea |
gptkb:Alzheimer's_disease
frontotemporal dementia |
| gptkbp:website |
https://www.arkudatx.com/
|
| gptkbp:bfsParent |
gptkb:Arsenal_Yards
|
| gptkbp:bfsLayer |
6
|